PTK2 and urinary bladder carcinoma: Peng et al. show that ROS targets the proto-oncogene tyrosine-protein kinase Src and the focal adhesion kinase (FAK) pathway, both of which are closely involved in motile crawling and invasive behavior of bladder cancer cells [53].